VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MEDS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MEDSDataMEDS AI, Inc.
$0.73$5M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMEDSEarnings History

MEDS logoDataMEDS AI, Inc. (MEDS) Earnings History

Net Loss

3 years of earnings data (2023–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$43M
● Net Loss
TTM EPS (Diluted)
$-10.95
Per share, diluted
YoY EPS Growth
-1000.0%
Declining
Net Margin
-433.9%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-347.9%
Gross Margin-41.3%
Return on EquityN/A
Return on Assets-230.7%
Record Annual Net Income-$3MFY2023
Record Quarterly EPS$2.67Q3 2026
Consecutive Profitable Years0years
Q3 2026
Net Income$11M
EPS (Diluted)$2.67
YoY Growth-1000.0%Declining
QoQ Growth+157.7%Excellent

Loading earnings history...

DataMEDS AI, Inc. (MEDS) Earnings Overview

As of November 21, 2026, DataMEDS AI, Inc. (MEDS) reported trailing twelve-month net income of -$43M, reflecting -1000.0% year-over-year growth. The company earned $-10.95 per diluted share over the past four quarters, with a net profit margin of -433.9%.

Looking at the long-term picture, MEDS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2023.

DataMEDS AI, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including HSIC ($421M net income, 3.0% margin), ACH (-$172M net income, -39.8% margin), HCSG ($105M net income, 3.2% margin), MEDS has room to improve margins relative to the peer group. Compare MEDS vs HSIC →

MEDS Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
MEDS logoMEDSCurrent
-$43M$-10.95-433.9%--1000.0%—
HSIC logoHSIC
$421M$3.743.0%8.3%+7.2%
ACH logoACH
-$172M--39.8%-2111.6%-202.5%
HCSG logoHCSG
$105M$1.513.2%11.7%+52.8%
MCK logoMCK
$4.7B$40.271.2%-+49.2%
CAH logoCAH
$1.8B$7.800.7%-+12.1%
Best in group
Lowest in group

MEDS Historical Earnings Data (2023–2025)

3 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$101M-1377.1%-$81M$-71.50-433.9%-347.9%
2024-$7M-136.8%-$6M$-6.50-37.8%-33.9%
2023-$3M--$3M$-3.00--

Download Data

Export MEDS earnings history in CSV or JSON format

Free sign-in required to download data

Consensus & Technical Research Suite
Open MEDS Terminal

MEDS Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

3+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MEDS — Frequently Asked Questions

Quick answers to the most common questions about buying MEDS stock.

What is MEDS earnings per share (EPS)?

MEDS trailing twelve-month (TTM) diluted EPS is $-10.95, reflecting -1000.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2023 to 2025 is available in the table on this page.

What is DataMEDS AI, Inc.'s net income?

DataMEDS AI, Inc. (MEDS) trailing twelve-month net income is $-43M as of 2025. Earnings declined -1000.0% year-over-year.

Is MEDS profitable?

MEDS is not currently profitable on a TTM basis, reporting a net loss of $-43M. Net margin is -433.9%. Investors should monitor for a return to profitability.

What is MEDS's earnings growth rate?

MEDS compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2023 to 2025.

What are MEDS's profit margins?

DataMEDS AI, Inc. net profit margin is -433.9%, operating margin is -347.9%, and gross margin is -41.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.

Is MEDS growing earnings?

MEDS earnings are declining — EPS fell -1000.0% year-over-year. TTM net income dropped to $-43M. This contrasts with the 5-year CAGR of N/A.

What was MEDS's best earnings year?

DataMEDS AI, Inc.'s highest annual net income on record is $-3M, achieved in fiscal year 2023. Earnings history on this page spans 2023 to 2025 and includes all annual and quarterly figures.

What were MEDS's earnings last quarter?

MEDS's most recent reported quarter was Q3 2026. Net income was $11M with diluted EPS of $2.67. For a full breakdown of all quarters, see the quarterly earnings table on this page.

MEDS Earnings Over Time (2023–2025)

Net income & EPS — annual and quarterly view